Rizwan Chaudhrey interviews Assurea’s Tanya Sharma, Catapult‘s Fernanda Masri, and Phacilitate‘s Becky Johnson-Kent at WIAT (#ATE2023) to get their perspective on the impact of Women in Advanced Therapies and what learnings they had gained from attending the WIAT event in Portugal.
Cell and Gene Therapy Distributed and Point-of-Care Manufacturing: Building Infrastructure and Capacity
Hear from our Co-founder, Krisha Patel, and CEO of Cellular Origins, Edwin Stone as they discuss the current challenges in building infrastructure and capacity for cell and gene therapy in this panel hosted by Carol Houts, CSO at Germfree. 📹 📢 Key Discussions:🔹 The use of automation tools and robotic solutions that support scale-up activities.
Dori Gonzalez-Acevedo CEO of ProcellaRX interviews Assurea’s Co-Founders, Tanya Sharma and Krisha Patel on the Women Leading Validation Podcast. They discuss their entrepreneurial journeys and share the Assurea story. They also share their perspectives on the current challenges and barriers in the biotech industry around digital compliance and the adoption of novel technologies. Listen to
(By Brian Buntz) Tanya Sharma, co-founder of the consulting firm Assurea LLC, helps clients in the life sciences industry navigate regulatory requirements. Sharma is an advocate for women in STEM and the life sciences. Sharma: I came to the U.S. when I was five years old and became interested in biomanufacturing. I worked in the labs
The article highlights the persistent challenges and disparities faced by women entrepreneurs in the United States, particularly in the biotech and pharmaceutical sectors. Despite women-owned businesses accounting for 40% of US enterprises, women-led startups received only 2.3% of venture capital funding in 2020. This imbalance is further exemplified by the fact that 92% of CEOs
Tanya Sharma was interviewed by Rizwan Chaudhrey of the RSK Life Science Media in London during Terrapinn’s Advanced Therapies Congress in May 2022 where Assurea participated in the Startup Zone. Rizwan met Tanya Sharma again in September 2022 at the Phacilitate Advanced Therapies UK event and recorded an update on ISPE Women in Pharma and
Data integrity translates into the consistency, completeness, and accuracy of data. It is required in all aspects of biopharmaceutical development and manufacturing, including emerging technologies like block chain, as you introduce them into your Quality Management Systems. Consistency, standardization, and traceability are some of the many issues we face when it comes to data integrity. Once
Tanya Sharma, Co-Founder of Assurea LLC and Najib Rehman from ATMPS were excited when invited to join Jesse McLaughlin, host of Modern Biopharma Podcast ,to talk about how Blockchain – a new technology that is exploding in our industry – can be used to help us make a jump towards more available therapies for more
Assurea LLC was launched in June 2020 with the mission of transforming the way we work and turning complexities into innovative solutions.